United States

Change in Pharma? Not optional. 10 Integrated imperatives for commercial model transformation

Apr 21, 2015
From the Healthcare & Life Sciences Institute

As growth rates decline, profitability stagnates and power centers shift, Big Pharma must undertake strategic commercial model transformation to remain viable.  KPMG recommends 10 integrated imperatives that pharmaceutical companies should consider as part of the transition to a more customer-focused future.